Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00418119

Enrollment

Registered

2007-01-04

Start date

2007-01-31

Completion date

2008-01-31

Last updated

2007-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Interventions

DRUGerythropoietin

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ischemic heart disease * Systolic lv dysfunction * Mild anemia * Normal renal function * Stable condition

Exclusion criteria

* Pregnancy * Unstable condition * Under 18 years old

Countries

Israel

Contacts

Primary ContactTuvia Ben Gal, MD

bengalt@clalit.org.il972-522757616

Backup ContactDaniel Murninkas, MD

murninkasd@clalit.org.il972-39376930

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026